Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4061308
[patent_doc_number] => 05866361
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/465273
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 65
[patent_no_of_words] => 24291
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866361.pdf
[firstpage_image] =>[orig_patent_app_number] => 465273
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465273 | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof | Jun 4, 1995 | Issued |
Array
(
[id] => 3922911
[patent_doc_number] => 05945300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Connective tissue growth factor-2'
[patent_app_type] => 1
[patent_app_number] => 8/459101
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11502
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945300.pdf
[firstpage_image] =>[orig_patent_app_number] => 459101
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459101 | Connective tissue growth factor-2 | Jun 1, 1995 | Issued |
08/456433 | NON-TOXIC, NON-TOXIGENIC, NON-PATHOGENIC FUSARIUM EXPRESSION SYSTEM AND PROMOTERS AND TERMINATORS FOR USE THEREIN | May 31, 1995 | Abandoned |
Array
(
[id] => 4062786
[patent_doc_number] => 06008019
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Plasminogen activator from saliva of the vampire bat'
[patent_app_type] => 1
[patent_app_number] => 8/456833
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 42
[patent_no_of_words] => 10180
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 459
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/008/06008019.pdf
[firstpage_image] =>[orig_patent_app_number] => 456833
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456833 | Plasminogen activator from saliva of the vampire bat | May 31, 1995 | Issued |
Array
(
[id] => 3805801
[patent_doc_number] => 05830876
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Genetic immunization'
[patent_app_type] => 1
[patent_app_number] => 8/453349
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 24723
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830876.pdf
[firstpage_image] =>[orig_patent_app_number] => 453349
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/453349 | Genetic immunization | May 29, 1995 | Issued |
Array
(
[id] => 4018454
[patent_doc_number] => 05925345
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => 'Vectors including foreign genes and negative selective markers'
[patent_app_type] => 1
[patent_app_number] => 8/450370
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 5593
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925345.pdf
[firstpage_image] =>[orig_patent_app_number] => 450370
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450370 | Vectors including foreign genes and negative selective markers | May 24, 1995 | Issued |
Array
(
[id] => 3876199
[patent_doc_number] => 05804409
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Production of active Pseudomonas glumae lipase in homologous or heterologous hosts'
[patent_app_type] => 1
[patent_app_number] => 8/449015
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 28
[patent_no_of_words] => 11112
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804409.pdf
[firstpage_image] =>[orig_patent_app_number] => 449015
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449015 | Production of active Pseudomonas glumae lipase in homologous or heterologous hosts | May 23, 1995 | Issued |
08/447610 | INTRACELLULAR IMMUNIZATION | May 22, 1995 | Abandoned |
Array
(
[id] => 3722385
[patent_doc_number] => 05672500
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same'
[patent_app_type] => 1
[patent_app_number] => 8/446925
[patent_app_country] => US
[patent_app_date] => 1995-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10619
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672500.pdf
[firstpage_image] =>[orig_patent_app_number] => 446925
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446925 | Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same | May 17, 1995 | Issued |
Array
(
[id] => 4061278
[patent_doc_number] => 05866359
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Transactivation method of regulating foreign gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/442646
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 9548
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866359.pdf
[firstpage_image] =>[orig_patent_app_number] => 442646
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442646 | Transactivation method of regulating foreign gene expression | May 15, 1995 | Issued |
Array
(
[id] => 3800267
[patent_doc_number] => 05853718
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Method of immunization using biologically contained bacterial cells'
[patent_app_type] => 1
[patent_app_number] => 8/434353
[patent_app_country] => US
[patent_app_date] => 1995-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 34
[patent_no_of_words] => 26239
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 402
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/853/05853718.pdf
[firstpage_image] =>[orig_patent_app_number] => 434353
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434353 | Method of immunization using biologically contained bacterial cells | May 1, 1995 | Issued |
08/432330 | GENES ENCODING BRANCHED CHAIN ALPHA-KETOACID DEHYDROGENASE COMPLEX FROM STREPTOMYCES AVERMITILIS | Apr 30, 1995 | Abandoned |
Array
(
[id] => 4051851
[patent_doc_number] => 05969124
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Nucleotide sequence of L1CAM'
[patent_app_type] => 1
[patent_app_number] => 8/427497
[patent_app_country] => US
[patent_app_date] => 1995-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 28595
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/969/05969124.pdf
[firstpage_image] =>[orig_patent_app_number] => 427497
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/427497 | Nucleotide sequence of L1CAM | Apr 23, 1995 | Issued |
Array
(
[id] => 3840135
[patent_doc_number] => 05847096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'DNA constructs encoding CD4 fusion proteins'
[patent_app_type] => 1
[patent_app_number] => 8/418848
[patent_app_country] => US
[patent_app_date] => 1995-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 64
[patent_no_of_words] => 23932
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/847/05847096.pdf
[firstpage_image] =>[orig_patent_app_number] => 418848
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/418848 | DNA constructs encoding CD4 fusion proteins | Apr 6, 1995 | Issued |
08/418096 | MODULATORS OF OB GENE AND SCREENING METHODS THEREFOR | Apr 4, 1995 | Abandoned |
08/408584 | MODULATORS OF OB GENE AND SCREENING METHODS THEREFOR | Mar 19, 1995 | Abandoned |
Array
(
[id] => 4144777
[patent_doc_number] => 06063613
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof'
[patent_app_type] => 1
[patent_app_number] => 8/403918
[patent_app_country] => US
[patent_app_date] => 1995-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 20116
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063613.pdf
[firstpage_image] =>[orig_patent_app_number] => 403918
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/403918 | Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof | Mar 14, 1995 | Issued |
08/404678 | NON-TOXIC, NON-TOXIGENIC, NON-PATHOGENIC FUSARIUM EXPRESSION SYSTEM AND PROMOTERS AND TERMINATORS FOR USE THEREIN | Mar 14, 1995 | Abandoned |
08/403576 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MALIGNANT TUMOR | Mar 13, 1995 | Abandoned |
08/395239 | PLASMID FOR EXPRESSING MODIFIED RECOMBINANT PROTEINS IN A BACTERIAL SYSTEM | Feb 26, 1995 | Abandoned |